soul trial oral semaglutide cardiovascular outcomes results 2024 2025 nejm The (Semaglutide Trial) was a randomized, double-blind, placebo-controlled cardiovascular outcomes trial that enrolled 9,650 patients aged 50 years or older with Forecasting Trial Milestones: A Predictive

This is still a growing problem and needs to be taken seriously

The combination of GLP-1's effect on insulin sensitivity and strength trainings ability to improve it can create a synergistic effect, making the body more efficient at using glucose and promoting fat loss while preserving muscle

We expect the number of cases in this MDL to continue to steadily rise as waves of new patients begin to take the drug without Novo Nordisks warning of potential harmful side effects such as stomach paralysis, bowel obstruction, and blindness

Then tirzepatide arrived and raised the bar, adding a second receptor target and delivering results that made semaglutide look modest by comparison

But you point out also the gut health aspects of it that are that cannot be underrated at all

It is administered via an injection pen and is prescribed in milligrams (mg)